256 related articles for article (PubMed ID: 24524733)
1. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
[TBL] [Abstract][Full Text] [Related]
2. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
[TBL] [Abstract][Full Text] [Related]
4. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
[TBL] [Abstract][Full Text] [Related]
7. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
[TBL] [Abstract][Full Text] [Related]
11. Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
Nandiwada SL; Peterson LK; Mayes MD; Jaskowski TD; Malmberg E; Assassi S; Satoh M; Tebo AE
J Rheumatol; 2016 Oct; 43(10):1816-1824. PubMed ID: 27481902
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
14. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
[TBL] [Abstract][Full Text] [Related]
17. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.
Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
J Dermatol; 2016 Jul; 43(7):808-10. PubMed ID: 26876001
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
Yayla ME; İlgen U; Düzgün N
Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
